Innobic (Asia) Co., Ltd., a wholly-owned subsidiary and life science arm of the national oil and gas conglomerate PTT, together with Aztiq HK Ltd., is acting on its promise to uplift Thailand’s life science business by completing a deal to buy out Alvogen Emerging Markets Holdings Ltd. (AEMH), raising Innobic’s shareholding in Taiwan-based Lotus Pharmaceutical Co., Ltd. to 37% from 6.6%.
The share purchase transaction, worth US$475 million, was officially celebrated at Four Seasons Bangkok Hotel on 9 May 2022, making Innobic a major shareholder in Lotus Pharmaceutical. AEMH was previously the major shareholder in Lotus Pharmaceutical.
Headquartered in Taiwan, Lotus Pharmaceutical was established in 1966.
The company is a leading generic drug manufacturing company primarily…
